Women who took Lipitor and developed Type 2 diabetes should call Wayne Wright immediately. The drug’s manufacturer hid the risk it posed for causing diabetes, especially in post-menopausal women.
After it was approved by the FDA in 1996, it became one of the most widely prescribed statins on the market. Scores of women took Lipitor to lower their cholesterol and protect themselves from strokes and heart attacks. Many may now have Type 2 diabetes, given the number who unknowingly took the drug.
Reuters reported in 2014 that Lipitor was “…prescribed for more than 29 million patients in the United States. The news agency called it the “best-selling prescription drug of all time,” reporting that Pfizer made “more than $130 billion from worldwide sales” of Lipitor.
It called Lipitor a “blockbuster anti-cholesterol drug” the public was never properly warned about.
After Lipitor went on the market in 1996, studies found that it “posed a high risk for causing new onset diabetes.” But Pfizer, the drug’s manufacturer, didn’t reveal Lipitor’s link to high blood sugar and diabetes until February 2012. The risk is higher for particular groups, including Asians, women and the elderly. Post-menopausal women face the greatest risk.
Lawsuits are now being filed against Pfizer, charging it with concealing Lipitor’s serious link to Type 2 diabetes and downplaying a warning about the drug that it was ordered to put on prescriptions by the U.S. Food and Drug Administration (FDA) in 2012.
Anyone, especially post-menopausal women who developed Type 2 diabetes after taking Lipitor, should call Wayne Wright at once for legal assistance. More than 1,000 lawsuits have now been filed against Pfizer for failing to properly warn all patients that they could develop Type 2 diabetes after taking Lipitor.